Anthony Marmarou

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Animal Physiology Biology, Neuroscience Biology, Medicine and Surgery
Google:
"Anthony Marmarou"
Mean distance: 53433
 
Cross-listing: Neurotrauma Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kleindienst A, Dunbar JG, Glisson R, et al. (2013) The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury. Acta Neurochirurgica. 155: 151-64
Lu J, Marmarou A, Lapane KL, et al. (2012) Impact of GOS misclassification on ordinal outcome analysis of traumatic brain injury clinical trials. Journal of Neurotrauma. 29: 719-26
Naff N, Williams MA, Keyl PM, et al. (2011) Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke; a Journal of Cerebral Circulation. 42: 3009-16
Prieto R, Tavazzi B, Taya K, et al. (2011) Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate. Brain Research. 1404: 39-49
Lingsma HF, Roozenbeek B, Li B, et al. (2011) Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study. Neurosurgery. 68: 601-7; discussion 60
Lu J, Marmarou A, Lapane K, et al. (2010) A method for reducing misclassification in the extended Glasgow Outcome Score. Journal of Neurotrauma. 27: 843-52
McHugh GS, Butcher I, Steyerberg EW, et al. (2010) A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project. Clinical Trials (London, England). 7: 44-57
Maas AI, Steyerberg EW, Marmarou A, et al. (2010) IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 127-34
Fazzina G, Amorini AM, Marmarou CR, et al. (2010) The protein kinase C activator phorbol myristate acetate decreases brain edema by aquaporin 4 downregulation after middle cerebral artery occlusion in the rat. Journal of Neurotrauma. 27: 453-61
Taya K, Marmarou CR, Okuno K, et al. (2010) Effect of secondary insults upon aquaporin-4 water channels following experimental cortical contusion in rats. Journal of Neurotrauma. 27: 229-39
See more...